眼部頸動脈夾層市場規模、佔有率和成長分析：按診斷方法、臨床症狀、治療方法、最終用戶和地區分類－2026-2033年產業預測

2024 年全球眼頸動脈夾層市場價值為 130 億美元，預計到 2033 年將從 2025 年的 136.5 億美元成長到 201.7 億美元，預測期（2026-2033 年）的複合年成長率為 5.0%。

全球眼部頸動脈夾層市場專注於診斷、介入器材和治療，旨在解決因眼部血流受損而威脅視力的頸動脈壁撕裂問題。早期發現和早期療育對於預防永久性視力喪失和降低中風風險至關重要。市場促進因素包括人們對眼部症狀血管病因的認知不斷提高、影像技術的進步以及血管併發症患者老化加劇。市場正朝著精準的血管內和外科治療方法方向發展，重點是頸動脈支架置放術和溶栓療法的日益普及。微創器械的技術創新透過提高安全性和治療可及性，推動了手術數量的成長，而個人化的診斷和治療方案則創造了巨大的市場機會。人工智慧技術的進步正在改善影像解讀和風險分層，簡化工作流程，並增強病患管理策略。

全球眼部頸動脈夾層市場成長要素

影像技術的進步和臨床醫生專業技能的提升顯著提高了對影響眼部血流的頸動脈夾層的早期準確檢出率。診斷準確率的提高增強了醫療專業人員進行標靶干預和專科治療的信心。影像診斷準確率的提高也推動了血管專家採用創新醫療設備和技術，因為這有助於選擇創傷較小的治療方法，並制定更有效率的治療計劃。因此，這一趨勢推動了各種醫療機構對專門用於眼部頸動脈夾層診療的診斷工具和治療方案的需求。

全球眼部頸動脈夾層市場的限制因素

全球眼頸動脈夾層市場面臨許多挑戰，其中最主要的原因是先進診斷技術、專用介入器材和手術全期護理的高成本。這些經濟障礙不僅阻礙了醫療服務提供者，也為患者帶來了許多不便，導致不同臨床機構的診療規範化程度有限。在健保報銷政策難以預測或不一致的情況下，醫療機構可能不願投資於必要的培訓和設備，以應對複雜的眼頸動脈夾層病例。這導致手術量減少，阻礙了市場成長。此外，人們普遍認為初始成本高於預期收益，這可能會進一步限制醫療機構的購買決策，並阻礙創新治療方法和技術的廣泛應用。

眼部頸動脈夾層的全球市場趨勢

全球頸動脈夾層市場正經歷一場重大變革，而遠距眼科醫療的整合正是推動這項變革的關鍵因素。這一趨勢透過促進遠距篩檢、影像共用以及血管和眼科多學科團隊之間的協作，提高了早期發現和治療的效率。虛擬平台透過加快分流流程、簡化轉診至專科醫生以及支援後續觀察，消除了地理限制，使患者能夠更便捷地獲得醫療服務。與門診診所和當地醫療機構的合作對於涵蓋醫療資源匱乏地區尤其重要。此外，改進的數位化工作流程和可互通的影像工具正在加強醫療協調，提高患者依從性，並確保醫療服務的連續性，最終實現及時干預和密切後續觀察。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球頸動脈夾層市場規模：依診斷方法分類

• MRA
• CTA
• 頸動脈雙極超音波檢查

全球頸動脈夾層市場規模：依臨床症狀分類

• 霍納氏症候群的治療
• 眼缺血症候群
• 顱神經麻痺

全球頸動脈夾層市場規模：依治療性介入

• 抗凝血治療/抗血小板治療
• 血管內支架置入術
• 手術結紮/修復

全球眼頸動脈夾層市場規模：依最終用戶分類

• 神經眼科診所
• 中風和血管治療單元
• 三級急診醫院

全球頸動脈夾層市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• GE HealthCare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Holdings
• Alcon Inc.
• Johnson & Johnson Vision
• Carl Zeiss Meditec
• Bausch+Lomb
• Glaukos Corp.
• Raumedic AG
• Medtronic
• Stryker
• Canon Medical Systems
• Nikon
• Topcon Corporation
• Heidelberg Engineering
• Haag-Streit
• EssilorLuxottica
• Hoya Corporation
• Nidek Co., Ltd.

結論與建議

Global Ocular Carotid Artery Dissection Market size was valued at USD 13.0 Billion in 2024 and is poised to grow from USD 13.65 Billion in 2025 to USD 20.17 Billion by 2033, growing at a CAGR of 5.0% during the forecast period (2026-2033).

The global ocular carotid artery dissection market focuses on diagnostics, interventional devices, and therapeutics addressing carotid artery wall tears that threaten vision through impaired ocular perfusion. Timely detection and intervention are critical in preventing permanent vision loss and reducing stroke risks. Key market drivers include heightened awareness of vascular causes of ocular symptoms, advancements in imaging technologies, and an aging population with vascular comorbidities. The market has progressed towards precise endovascular and surgical methods, emphasizing the increased usage of carotid stenting and thrombolysis. Technological innovations in minimally invasive devices are fostering higher procedure volumes by enhancing safety and treatment accessibility, while tailored diagnostic and therapeutic options are generating significant market opportunities. As AI technologies advance, they are enhancing imaging interpretation and risk stratification, streamlining workflows, and improving patient management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ocular Carotid Artery Dissection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ocular Carotid Artery Dissection Market Segments Analysis

Global ocular carotid artery dissection market is segmented by diagnostic modality, clinical presentation, treatment intervention, end-user and region. Based on diagnostic modality, the market is segmented into MRA, CTA and Carotid Duplex Ultrasonography. Based on clinical presentation, the market is segmented into Horner's Syndrome Management, Ocular Ischemic Syndrome and Cranial Nerve Palsies. Based on treatment intervention, the market is segmented into Anticoagulation/Antiplatelet Therapy, Endovascular Stenting and Surgical Ligation/Repair. Based on end-user, the market is segmented into Neuro-Ophthalmology Clinics, Stroke & Vascular Units and Tertiary Emergency Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ocular Carotid Artery Dissection Market

Advancements in diagnostic imaging technologies and heightened clinician expertise are significantly enhancing the early and precise detection of carotid artery dissections that impact ocular blood flow. This increase in diagnostic accuracy bolsters healthcare professionals' confidence in implementing targeted interventions and specialized therapies. Improved visualization aids in the choice of less invasive treatment options and streamlines procedural planning, promoting the uptake of innovative devices and techniques among vascular specialists. Consequently, this trend boosts the demand for both diagnostic tools and therapeutic solutions specifically designed for managing ocular carotid artery dissections across various healthcare environments.

Restraints in the Global Ocular Carotid Artery Dissection Market

The Global Ocular Carotid Artery Dissection market faces notable challenges due to the high costs linked to advanced diagnostic techniques, specialized interventional tools, and perioperative care. These financial hurdles create obstacles for both healthcare providers and patients, resulting in limited standardization of practices across various clinical settings. In environments where reimbursement policies are unpredictable or inconsistent, institutions may hesitate to invest in essential training and equipment needed for addressing complex ocular carotid artery dissections. Consequently, this leads to reduced procedure volumes, inhibiting market growth. Additionally, the perception of high initial expenses compared to the expected incremental benefits can further restrict purchasing decisions and impede the broader adoption of innovative therapies and technologies.

Market Trends of the Global Ocular Carotid Artery Dissection Market

The Global Ocular Carotid Artery Dissection market is experiencing a significant shift driven by the integration of teleophthalmology. This trend is enhancing early detection and management by facilitating remote screening, image sharing, and collaboration among multidisciplinary teams in vascular and eye care. Virtual platforms accelerate triage processes, simplify referrals to specialists, and support follow-up monitoring, thereby removing geographic barriers to access. The collaboration with ambulatory clinics and community providers is particularly crucial for reaching underserved areas. Furthermore, improved digital workflows and interoperable imaging tools are fostering better care coordination, enhancing patient adherence, and ensuring continuity of care, ultimately enabling timely interventions and closer surveillance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Ocular Carotid Artery Dissection Market Size by Diagnostic Modality & CAGR (2026-2033)

• Market Overview
• MRA
• CTA
• Carotid Duplex Ultrasonography

Global Ocular Carotid Artery Dissection Market Size by Clinical Presentation & CAGR (2026-2033)

• Market Overview
• Horner's Syndrome Management
• Ocular Ischemic Syndrome
• Cranial Nerve Palsies

Global Ocular Carotid Artery Dissection Market Size by Treatment Intervention & CAGR (2026-2033)

• Market Overview
• Anticoagulation/Antiplatelet Therapy
• Endovascular Stenting
• Surgical Ligation/Repair

Global Ocular Carotid Artery Dissection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Neuro-Ophthalmology Clinics
• Stroke & Vascular Units
• Tertiary Emergency Hospitals

Global Ocular Carotid Artery Dissection Market Size & CAGR (2026-2033)

• North America (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • US
  • Canada
• Europe (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glaukos Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Raumedic AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heidelberg Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haag-Streit
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EssilorLuxottica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations